Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - DE000A0JM2M1 - Common Stock

20.2 EUR
0 (0%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, B7E scores 5 out of 10 in our fundamental rating. B7E was compared to 109 industry peers in the Capital Markets industry. B7E has an average financial health and profitability rating. B7E has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

B7E had positive earnings in the past year.
B7E had a positive operating cash flow in the past year.
B7E had positive earnings in 4 of the past 5 years.
In the past 5 years B7E always reported a positive cash flow from operatings.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

The Return On Assets of B7E (6.14%) is better than 78.90% of its industry peers.
B7E has a Return On Equity of 13.94%. This is in the better half of the industry: B7E outperforms 74.31% of its industry peers.
With a decent Return On Invested Capital value of 3.95%, B7E is doing good in the industry, outperforming 65.14% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 8.66%.
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROIC 3.95%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

B7E's Profit Margin of 6.44% is in line compared to the rest of the industry. B7E outperforms 50.46% of its industry peers.
In the last couple of years the Profit Margin of B7E has grown nicely.
B7E has a Operating Margin (4.18%) which is comparable to the rest of the industry.
B7E's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 50.05%, B7E is in the better half of the industry, outperforming 67.89% of the companies in the same industry.
B7E's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
The number of shares outstanding for B7E has been increased compared to 5 years ago.
B7E has a better debt/assets ratio than last year.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.22 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
B7E has a Altman-Z score of 2.22. This is in the better half of the industry: B7E outperforms 66.06% of its industry peers.
B7E has a debt to FCF ratio of 9.68. This is a negative value and a sign of low solvency as B7E would need 9.68 years to pay back of all of its debts.
The Debt to FCF ratio of B7E (9.68) is better than 67.89% of its industry peers.
B7E has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.38, B7E perfoms like the industry average, outperforming 59.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Altman-Z 2.22
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.65 indicates that B7E should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.65, B7E is in the better half of the industry, outperforming 75.23% of the companies in the same industry.
A Quick Ratio of 1.36 indicates that B7E should not have too much problems paying its short term obligations.
B7E has a better Quick ratio (1.36) than 70.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.36
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 172.52% over the past year.
The Earnings Per Share has been growing by 33.00% on average over the past years. This is a very strong growth
Looking at the last year, B7E shows a decrease in Revenue. The Revenue has decreased by -5.86% in the last year.
B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%

3.2 Future

B7E is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.17% yearly.
Based on estimates for the next years, B7E will show a decrease in Revenue. The Revenue will decrease by -5.29% on average per year.
EPS Next Y-81.62%
EPS Next 2Y-50%
EPS Next 3Y-28.17%
EPS Next 5YN/A
Revenue Next Year-11.8%
Revenue Next 2Y-4.42%
Revenue Next 3Y-1.29%
Revenue Next 5Y-5.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.94, the valuation of B7E can be described as very cheap.
92.66% of the companies in the same industry are more expensive than B7E, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of B7E to the average of the S&P500 Index (27.03), we can say B7E is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 24.29, the valuation of B7E can be described as rather expensive.
61.47% of the companies in the same industry are more expensive than B7E, based on the Price/Forward Earnings ratio.
B7E is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.94
Fwd PE 24.29
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, B7E is valued cheaper than 90.83% of the companies in the same industry.
85.32% of the companies in the same industry are more expensive than B7E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.48
EV/EBITDA 4.19
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of B7E may justify a higher PE ratio.
A cheap valuation may be justified as B7E's earnings are expected to decrease with -28.17% in the coming years.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y-50%
EPS Next 3Y-28.17%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.25%, B7E has a reasonable but not impressive dividend return.
B7E's Dividend Yield is a higher than the industry average which is at 6.20.
B7E's Dividend Yield is a higher than the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.25%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

B7E pays out 21.99% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP21.99%
EPS Next 2Y-50%
EPS Next 3Y-28.17%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
B7E.DE Dividend Payout.B7E.DE Dividend Payout, showing the Payout Ratio.B7E.DE Dividend Payout.PayoutRetained Earnings

BLUE CAP AG

FRA:B7E (9/9/2025, 7:00:00 PM)

20.2

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-20 2025-08-20
Earnings (Next)10-21 2025-10-21
Inst Owners25.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap90.70M
Analysts82.86
Price Target30.67 (51.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.25%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP21.99%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.22%
PT rev (3m)-1.42%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.26%
EPS NY rev (3m)-4.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.62%
Revenue NY rev (3m)-12.92%
Valuation
Industry RankSector Rank
PE 6.94
Fwd PE 24.29
P/S 0.44
P/FCF 11.48
P/OCF 6.98
P/B 0.95
P/tB 2.03
EV/EBITDA 4.19
EPS(TTM)2.91
EY14.41%
EPS(NY)0.83
Fwd EY4.12%
FCF(TTM)1.76
FCFY8.71%
OCF(TTM)2.89
OCFY14.33%
SpS45.86
BVpS21.18
TBVpS9.95
PEG (NY)N/A
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROCE 5.68%
ROIC 3.95%
ROICexc 6.3%
ROICexgc 13.24%
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
FCFM 3.84%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexcg growth 3Y54.39%
ROICexcg growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Debt/EBITDA 1.4
Cap/Depr 29.84%
Cap/Sales 2.47%
Interest Coverage 1.83
Cash Conversion 50.62%
Profit Quality 59.6%
Current Ratio 1.65
Quick Ratio 1.36
Altman-Z 2.22
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
EPS Next Y-81.62%
EPS Next 2Y-50%
EPS Next 3Y-28.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%
Revenue Next Year-11.8%
Revenue Next 2Y-4.42%
Revenue Next 3Y-1.29%
Revenue Next 5Y-5.29%
EBIT growth 1Y33.24%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-18.41%
EBIT Next 3Y-0.89%
EBIT Next 5Y-12.8%
FCF growth 1Y-21.47%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-11.77%
OCF growth 3Y1.47%
OCF growth 5Y47.8%